Summary
Centene Corporation (CNC) reported significant growth in its third quarter and nine-month period ended September 30, 2002. Total revenues increased due to a substantial rise in membership across its Medicaid and SCHIP programs, driven by organic growth and strategic acquisitions. The company's financial performance benefited from a one-time dividend from an investment in a captive insurance company, which boosted other income significantly for both the quarter and the year-to-date period. While operational expenses, particularly medical services costs, also increased in line with membership growth, Centene demonstrated improved efficiency with a slight reduction in its general and administrative expense ratio. The company's balance sheet shows growth in long-term investments and a robust increase in stockholders' equity, largely due to a successful follow-on public offering in May 2002. Centene's liquidity remains sufficient, with substantial cash, cash equivalents, and investments on hand to fund operations and anticipated capital expenditures.
Key Highlights
- 1Total revenues for the nine months ended September 30, 2002, increased by 35.4% to $319.4 million compared to the prior year, driven by membership growth and increased premium rates.
- 2Net earnings attributable to common stockholders for the nine months ended September 30, 2002, were $18.8 million, a significant increase from $8.6 million in the same period of 2001.
- 3Membership grew by 31.7% year-over-year, reaching 296,100 members, with notable increases in Wisconsin, Indiana, and Texas.
- 4A one-time dividend of $5.1 million from a captive insurance investment substantially boosted 'Other Income,' contributing to the overall earnings increase.
- 5The company successfully completed a follow-on public offering in May 2002, raising $10.3 million in net proceeds, which bolstered its capital position.
- 6Centene is actively pursuing strategic acquisitions, including an agreement to acquire 80% of University Health Plans, Inc. (UHP) in New Jersey, which will expand its market reach.
- 7The health benefits ratio remained stable at 82.2% for both the nine-month periods, indicating effective management of medical costs relative to premium revenues.